Molecular and cellular changes in the post-traumatic spinal cord remodeling after autoinfusion of a genetically-enriched leucoconcentrate in a mini-pig model

Post-traumatic spinal cord remodeling includes both degenerating and regenerating processes, which affect the potency of the functional recovery after spinal cord injury (SCI). Gene therapy for spinal cord injury is proposed as a promising therapeutic strategy to induce positive changes in remodelin...

Full description

Bibliographic Details
Main Authors: Maria Aleksandrovna Davleeva, Ravil Rasimovich Garifulin, Farid Vagizovich Bashirov, Andrei Aleksandrovich Izmailov, Leniz Faritovich Nurullin, Ilnur Ildusovich Salafutdinov, Dilara Zilbarovna Gatina, Dmitrij Nikolaevich Shcherbinin, Andrei Aleksandrovich Lysenko, Irina Leonidovna Tutykhina, Maksim Mikhailovich Shmarov, Rustem Robertovich Islamov
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=7;spage=1505;epage=1511;aulast=Davleeva
_version_ 1797954695811039232
author Maria Aleksandrovna Davleeva
Ravil Rasimovich Garifulin
Farid Vagizovich Bashirov
Andrei Aleksandrovich Izmailov
Leniz Faritovich Nurullin
Ilnur Ildusovich Salafutdinov
Dilara Zilbarovna Gatina
Dmitrij Nikolaevich Shcherbinin
Andrei Aleksandrovich Lysenko
Irina Leonidovna Tutykhina
Maksim Mikhailovich Shmarov
Rustem Robertovich Islamov
author_facet Maria Aleksandrovna Davleeva
Ravil Rasimovich Garifulin
Farid Vagizovich Bashirov
Andrei Aleksandrovich Izmailov
Leniz Faritovich Nurullin
Ilnur Ildusovich Salafutdinov
Dilara Zilbarovna Gatina
Dmitrij Nikolaevich Shcherbinin
Andrei Aleksandrovich Lysenko
Irina Leonidovna Tutykhina
Maksim Mikhailovich Shmarov
Rustem Robertovich Islamov
author_sort Maria Aleksandrovna Davleeva
collection DOAJ
description Post-traumatic spinal cord remodeling includes both degenerating and regenerating processes, which affect the potency of the functional recovery after spinal cord injury (SCI). Gene therapy for spinal cord injury is proposed as a promising therapeutic strategy to induce positive changes in remodeling of the affected neural tissue. In our previous studies for delivering the therapeutic genes at the site of spinal cord injury, we developed a new approach using an autologous leucoconcentrate transduced ex vivo with chimeric adenoviruses (Ad5/35) carrying recombinant cDNA. In the present study, the efficacy of the intravenous infusion of an autologous genetically-enriched leucoconcentrate simultaneously producing recombinant vascular endothelial growth factor (VEGF), glial cell line-derived neurotrophic factor (GDNF), and neural cell adhesion molecule (NCAM) was evaluated with regard to the molecular and cellular changes in remodeling of the spinal cord tissue at the site of damage in a model of mini-pigs with moderate spinal cord injury. Experimental animals were randomly divided into two groups of 4 pigs each: the therapeutic (infused with the leucoconcentrate simultaneously transduced with a combination of the three chimeric adenoviral vectors Ad5/35‐VEGF165, Ad5/35‐GDNF, and Ad5/35‐NCAM1) and control groups (infused with intact leucoconcentrate). The morphometric and immunofluorescence analysis of the spinal cord regeneration in the rostral and caudal segments according to the epicenter of the injury in the treated animals compared to the control mini-pigs showed: (1) higher sparing of the grey matter and increased survivability of the spinal cord cells (lower number of Caspase-3-positive cells and decreased expression of Hsp27); (2) recovery of synaptophysin expression; (3) prevention of astrogliosis (lower area of glial fibrillary acidic protein-positive astrocytes and ionized calcium binding adaptor molecule 1-positive microglial cells); (4) higher growth rates of regenerating βIII-tubulin-positive axons accompanied by a higher number of oligodendrocyte transcription factor 2-positive oligodendroglial cells in the lateral corticospinal tract region. These results revealed the efficacy of intravenous infusion of the autologous genetically-enriched leucoconcentrate producing recombinant VEGF, GDNF, and NCAM in the acute phase of spinal cord injury on the positive changes in the post-traumatic remodeling nervous tissue at the site of direct injury. Our data provide a solid platform for a new ex vivo gene therapy for spinal cord injury and will facilitate further translation of regenerative therapies in clinical neurology.
first_indexed 2024-04-10T23:22:38Z
format Article
id doaj.art-01daf75aacbd4da89e5f9077f6746366
institution Directory Open Access Journal
issn 1673-5374
language English
last_indexed 2024-04-10T23:22:38Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj.art-01daf75aacbd4da89e5f9077f67463662023-01-12T13:29:30ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742023-01-011871505151110.4103/1673-5374.360241Molecular and cellular changes in the post-traumatic spinal cord remodeling after autoinfusion of a genetically-enriched leucoconcentrate in a mini-pig modelMaria Aleksandrovna DavleevaRavil Rasimovich GarifulinFarid Vagizovich BashirovAndrei Aleksandrovich IzmailovLeniz Faritovich NurullinIlnur Ildusovich SalafutdinovDilara Zilbarovna GatinaDmitrij Nikolaevich ShcherbininAndrei Aleksandrovich LysenkoIrina Leonidovna TutykhinaMaksim Mikhailovich ShmarovRustem Robertovich IslamovPost-traumatic spinal cord remodeling includes both degenerating and regenerating processes, which affect the potency of the functional recovery after spinal cord injury (SCI). Gene therapy for spinal cord injury is proposed as a promising therapeutic strategy to induce positive changes in remodeling of the affected neural tissue. In our previous studies for delivering the therapeutic genes at the site of spinal cord injury, we developed a new approach using an autologous leucoconcentrate transduced ex vivo with chimeric adenoviruses (Ad5/35) carrying recombinant cDNA. In the present study, the efficacy of the intravenous infusion of an autologous genetically-enriched leucoconcentrate simultaneously producing recombinant vascular endothelial growth factor (VEGF), glial cell line-derived neurotrophic factor (GDNF), and neural cell adhesion molecule (NCAM) was evaluated with regard to the molecular and cellular changes in remodeling of the spinal cord tissue at the site of damage in a model of mini-pigs with moderate spinal cord injury. Experimental animals were randomly divided into two groups of 4 pigs each: the therapeutic (infused with the leucoconcentrate simultaneously transduced with a combination of the three chimeric adenoviral vectors Ad5/35‐VEGF165, Ad5/35‐GDNF, and Ad5/35‐NCAM1) and control groups (infused with intact leucoconcentrate). The morphometric and immunofluorescence analysis of the spinal cord regeneration in the rostral and caudal segments according to the epicenter of the injury in the treated animals compared to the control mini-pigs showed: (1) higher sparing of the grey matter and increased survivability of the spinal cord cells (lower number of Caspase-3-positive cells and decreased expression of Hsp27); (2) recovery of synaptophysin expression; (3) prevention of astrogliosis (lower area of glial fibrillary acidic protein-positive astrocytes and ionized calcium binding adaptor molecule 1-positive microglial cells); (4) higher growth rates of regenerating βIII-tubulin-positive axons accompanied by a higher number of oligodendrocyte transcription factor 2-positive oligodendroglial cells in the lateral corticospinal tract region. These results revealed the efficacy of intravenous infusion of the autologous genetically-enriched leucoconcentrate producing recombinant VEGF, GDNF, and NCAM in the acute phase of spinal cord injury on the positive changes in the post-traumatic remodeling nervous tissue at the site of direct injury. Our data provide a solid platform for a new ex vivo gene therapy for spinal cord injury and will facilitate further translation of regenerative therapies in clinical neurology.http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=7;spage=1505;epage=1511;aulast=Davleevaautologous genetically-enriched leucoconcentrate; chimeric adenoviral vector; gene therapy; glial cell line‐derived neurotrophic factor; mini-pig; neural cell adhesion molecule; spinal cord contusion injury; vascular endothelial growth factor
spellingShingle Maria Aleksandrovna Davleeva
Ravil Rasimovich Garifulin
Farid Vagizovich Bashirov
Andrei Aleksandrovich Izmailov
Leniz Faritovich Nurullin
Ilnur Ildusovich Salafutdinov
Dilara Zilbarovna Gatina
Dmitrij Nikolaevich Shcherbinin
Andrei Aleksandrovich Lysenko
Irina Leonidovna Tutykhina
Maksim Mikhailovich Shmarov
Rustem Robertovich Islamov
Molecular and cellular changes in the post-traumatic spinal cord remodeling after autoinfusion of a genetically-enriched leucoconcentrate in a mini-pig model
Neural Regeneration Research
autologous genetically-enriched leucoconcentrate; chimeric adenoviral vector; gene therapy; glial cell line‐derived neurotrophic factor; mini-pig; neural cell adhesion molecule; spinal cord contusion injury; vascular endothelial growth factor
title Molecular and cellular changes in the post-traumatic spinal cord remodeling after autoinfusion of a genetically-enriched leucoconcentrate in a mini-pig model
title_full Molecular and cellular changes in the post-traumatic spinal cord remodeling after autoinfusion of a genetically-enriched leucoconcentrate in a mini-pig model
title_fullStr Molecular and cellular changes in the post-traumatic spinal cord remodeling after autoinfusion of a genetically-enriched leucoconcentrate in a mini-pig model
title_full_unstemmed Molecular and cellular changes in the post-traumatic spinal cord remodeling after autoinfusion of a genetically-enriched leucoconcentrate in a mini-pig model
title_short Molecular and cellular changes in the post-traumatic spinal cord remodeling after autoinfusion of a genetically-enriched leucoconcentrate in a mini-pig model
title_sort molecular and cellular changes in the post traumatic spinal cord remodeling after autoinfusion of a genetically enriched leucoconcentrate in a mini pig model
topic autologous genetically-enriched leucoconcentrate; chimeric adenoviral vector; gene therapy; glial cell line‐derived neurotrophic factor; mini-pig; neural cell adhesion molecule; spinal cord contusion injury; vascular endothelial growth factor
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2023;volume=18;issue=7;spage=1505;epage=1511;aulast=Davleeva
work_keys_str_mv AT mariaaleksandrovnadavleeva molecularandcellularchangesintheposttraumaticspinalcordremodelingafterautoinfusionofageneticallyenrichedleucoconcentrateinaminipigmodel
AT ravilrasimovichgarifulin molecularandcellularchangesintheposttraumaticspinalcordremodelingafterautoinfusionofageneticallyenrichedleucoconcentrateinaminipigmodel
AT faridvagizovichbashirov molecularandcellularchangesintheposttraumaticspinalcordremodelingafterautoinfusionofageneticallyenrichedleucoconcentrateinaminipigmodel
AT andreialeksandrovichizmailov molecularandcellularchangesintheposttraumaticspinalcordremodelingafterautoinfusionofageneticallyenrichedleucoconcentrateinaminipigmodel
AT lenizfaritovichnurullin molecularandcellularchangesintheposttraumaticspinalcordremodelingafterautoinfusionofageneticallyenrichedleucoconcentrateinaminipigmodel
AT ilnurildusovichsalafutdinov molecularandcellularchangesintheposttraumaticspinalcordremodelingafterautoinfusionofageneticallyenrichedleucoconcentrateinaminipigmodel
AT dilarazilbarovnagatina molecularandcellularchangesintheposttraumaticspinalcordremodelingafterautoinfusionofageneticallyenrichedleucoconcentrateinaminipigmodel
AT dmitrijnikolaevichshcherbinin molecularandcellularchangesintheposttraumaticspinalcordremodelingafterautoinfusionofageneticallyenrichedleucoconcentrateinaminipigmodel
AT andreialeksandrovichlysenko molecularandcellularchangesintheposttraumaticspinalcordremodelingafterautoinfusionofageneticallyenrichedleucoconcentrateinaminipigmodel
AT irinaleonidovnatutykhina molecularandcellularchangesintheposttraumaticspinalcordremodelingafterautoinfusionofageneticallyenrichedleucoconcentrateinaminipigmodel
AT maksimmikhailovichshmarov molecularandcellularchangesintheposttraumaticspinalcordremodelingafterautoinfusionofageneticallyenrichedleucoconcentrateinaminipigmodel
AT rustemrobertovichislamov molecularandcellularchangesintheposttraumaticspinalcordremodelingafterautoinfusionofageneticallyenrichedleucoconcentrateinaminipigmodel